VULTAGGIO, ALESSANDRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.180
EU - Europa 5.312
AS - Asia 3.662
SA - Sud America 547
AF - Africa 72
OC - Oceania 65
Continente sconosciuto - Info sul continente non disponibili 1
Totale 16.839
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.108
RU - Federazione Russa 1.993
SG - Singapore 1.207
PL - Polonia 1.134
CN - Cina 890
IT - Italia 610
HK - Hong Kong 587
BR - Brasile 438
SE - Svezia 405
IE - Irlanda 373
KR - Corea 350
DE - Germania 215
VN - Vietnam 194
FI - Finlandia 171
GB - Regno Unito 121
IN - India 110
JO - Giordania 90
UA - Ucraina 75
FR - Francia 72
AU - Australia 62
TR - Turchia 54
AR - Argentina 52
ID - Indonesia 47
JP - Giappone 37
NL - Olanda 35
CH - Svizzera 34
CA - Canada 32
MX - Messico 24
BD - Bangladesh 20
BE - Belgio 20
CI - Costa d'Avorio 20
EC - Ecuador 18
ES - Italia 18
ZA - Sudafrica 15
IQ - Iraq 12
VE - Venezuela 12
IL - Israele 10
MA - Marocco 10
CZ - Repubblica Ceca 9
UY - Uruguay 9
AE - Emirati Arabi Uniti 8
AT - Austria 7
CO - Colombia 6
LT - Lituania 5
PK - Pakistan 5
UZ - Uzbekistan 5
BJ - Benin 4
JM - Giamaica 4
NG - Nigeria 4
PA - Panama 4
PE - Perù 4
PY - Paraguay 4
SA - Arabia Saudita 4
TN - Tunisia 4
AZ - Azerbaigian 3
CL - Cile 3
EG - Egitto 3
LV - Lettonia 3
NP - Nepal 3
PH - Filippine 3
SC - Seychelles 3
TH - Thailandia 3
BB - Barbados 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GE - Georgia 2
GR - Grecia 2
IR - Iran 2
KZ - Kazakistan 2
LK - Sri Lanka 2
MY - Malesia 2
NC - Nuova Caledonia 2
PS - Palestinian Territory 2
AL - Albania 1
AM - Armenia 1
BF - Burkina Faso 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CR - Costa Rica 1
ET - Etiopia 1
GA - Gabon 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
KE - Kenya 1
KG - Kirghizistan 1
LB - Libano 1
LU - Lussemburgo 1
MD - Moldavia 1
MN - Mongolia 1
MU - Mauritius 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
QA - Qatar 1
RO - Romania 1
Totale 16.834
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.503
Warsaw 1.130
Ashburn 862
Singapore 828
Fairfield 584
Hong Kong 501
Chandler 445
Dublin 373
Seoul 350
Hefei 262
Cambridge 241
Seattle 230
Beijing 229
Houston 223
Woodbridge 223
Wilmington 216
San Jose 147
Ann Arbor 144
Buffalo 134
Florence 132
Jacksonville 118
Lawrence 118
Altamura 116
Munich 111
Los Angeles 109
Princeton 96
Dallas 90
Moscow 89
New York 76
Boston 67
Boardman 66
The Dalles 65
Mumbai 62
Melbourne 59
Shanghai 57
Ho Chi Minh City 55
Hanoi 53
Kent 53
Paris 47
Medford 45
Milan 43
Turku 43
Helsinki 40
San Diego 38
Jakarta 37
Izmir 35
São Paulo 35
Dong Ket 24
London 22
Luni 22
Lappeenranta 21
Abidjan 20
Norwalk 20
Rome 20
Brooklyn 19
Chicago 18
Tokyo 18
Bern 17
Brussels 17
Falls Church 17
Frankfurt am Main 17
Clifton 16
Redondo Beach 16
Phoenix 14
Washington 14
Naples 13
Yubileyny 13
Zurich 13
Tianjin 12
Toronto 12
Xi'an 12
Salerno 11
Andover 10
Johannesburg 10
Madrid 10
Tel Aviv 10
Brasília 9
Bremen 9
Denver 9
Mexico City 9
Orem 9
Osaka 9
Rio de Janeiro 9
Salt Lake City 9
Ankara 8
Atlanta 8
Bengaluru 8
Montreal 8
Salvador 8
Stockholm 8
Chennai 7
Curitiba 7
Fortaleza 7
Liverpool 7
Livorno 7
Manchester 7
Porto Alegre 7
Buenos Aires 6
Campinas 6
Chandigarh 6
Totale 11.225
Salva come PNG Salva come JPEG
Nome #
A novel allergen-adjuvant conjugate suitable for specific immunotherapy of respiratory allergy 343
Treatment with 8-OH-modified adenine (TLR7 ligand)-allergen conjugates decreases T helper type 2-oriented murine airway inflammation 337
Hapten-Specific TH17 Cells in the Peripheral Blood of β-Lactam-Induced AGEP. 308
Dermatophagoides pteronyssinus group 2 allergen bound to 8-OH modified adenine reduces the Th2-mediated airway inflammation without inducing a Th17 response and autoimmunity 283
Potential underestimation of risks in hazelnuts-allergic patients: a peculiar case report 250
The in vitro amplification of β-lactam-specific memory t cells improves the diagnostic performance of IGE detection and lymphocyte transformation test 238
Shift from intravenous or 16% subcutaneous replacement therapy to 20% subcutaneous immunoglobulin in patients with primary antibody deficiencies 221
Tocilizumab in Giant Cell Arteritis: A Real-Life Retrospective Study 221
Mepolizumab Reduces Inflammatory Eosinophils in Nasal Polyp Tissue and Restores Histological Alterations 220
T cells specific for Candida albicans antigens and producing type 2 cytokines in lesional mucosa of untreated HIV-infected patients with pseudomembranous oropharyngeal candidiasis. 217
Efficacy and safety of mepolizumab (Anti-Interleukin-5) treatment in Gleich's syndrome 212
Biweekly hizentra® in primary immunodeficiency: A multicenter, observational cohort study (IBIS) 206
High serum β-lactams specific/total IgE ratio is associated with immediate reactions to β-lactams antibiotics 191
High proportion of inflammatory CD62Llow eosinophils in blood and nasal polyps of severe asthma patients 189
Th2-oriented profile of male offspring T cells present in women with systemic sclerosis and reactive with maternal major histocompatibility complex antigens. 188
Assessment of the risk of polyomavirus JC reactivation in patients with immune-mediated diseases during long-term treatment with infliximab 184
The TLR7 Ligand 9-Benzyl-2-Butoxy-8-Hydroxy Adenine Inhibits IL-17 Response by Eliciting IL-10 and IL-10-Inducing Cytokines. 184
Assays and strategies for immunogenicity assessment of biological agents. 181
Skin testing and infliximab-specific antibodies detection as a combined strategy for preventing infusion reaction. 179
Early experience of an infectious and tropical diseases unit during the coronavirus disease (COVID-19) pandemic, Florence, Italy, February to March 2020 178
Asthma control in severe asthmatics under treatment with omalizumab: A cross-sectional observational study in Italy 176
Microchimerism and systemic sclerosis 175
Subcutaneous Immunoglobulin Replacement Therapy in Patients with Primary Immunodeficiency in Routine Clinical Practice: The VISPO Prospective Multicenter Study 173
Blood CD62Llow inflammatory eosinophils are related to the severity of asthma and reduced by mepolizumab 171
Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes 171
Detection by flow cytometry of ESAT-6- and PPD-specific circulating CD4+ T lymphocytes as a diagnostic tool for tuberculosis. 168
Miescher's cheilitis: Surgical management and long term outcome of an extremely severe case. 168
Anti-infliximab IgE and non-IgE antibodies and induction of infusion-related severe anaphylactic reactions. 166
A novel allergen-adjuvant conjugate suitable for allergen-specific Th2 redirection 166
Corrigendum to "Rapid infusions of human normal immunoglobulin 50g/l are safe and well tolerated in immunodeficiencies and immune thrombocytopenia" [Int. Immunopharmacol. 44 (2017) 38-42] 166
The percentage of patients achieving complete remission of urticaria increases with repeated courses of treatment 163
Drug-Specific Th2 Cells and IgE Antibodies in a Patient with Anaphylaxis to Rituximab 162
Omalizumab dampens type 2 inflammation in a group of long-term treated asthma patients and detaches IgE from FcεRI 162
Vav1 haploinsufficiency in a common variable immunodeficiency patient with defective T-cell function. 160
A novel nDer p2-conjugated TLR7 down-modulates Th2-associated lung inflammation by using a therapeutical protocol 154
Manifestations of Antidrug Antibodies Response: Hypersensitivity and Infusion Reactions. 151
Redirection of allergen-specific Th2 responses by a modified adenine through Toll-like receptor 7 interaction and IL-12/IFN release 150
PS1-076. Redirection of allergen-specific TH2 cells by a modified adenine chemically coupled to allergenic molecule(s) 150
Subcutaneous Immunoglobulin Twenty Percent Every Two Weeks in Pediatric Patients with Primary Immunodeficiencies: Subcohort Analysis of the IBIS Study 150
A modified adenine chemically coupled to allergenic molecule(s) as inducer of allergen-specific Th2 cells redirection 149
Can SSRI/SNRI antidepressants decrease the 'cytokine storm' in the course of COVID-19 pneumonia? 149
Seasonal Allergic Rhinitis Symptoms in Relation to COVID-19 148
Defective production of LIF, M-CSF and Th2-type cytokines by T cells at fetomaternal interface is associated with pregnancy loss. 147
A modified adenines chemically coupled to allergen molecule of dermatophagoides pteronyssinus down-regulates allergen-specific Th2 cells responses 147
Rapid infusions of human normal immunoglobulin 50g/l are safe and well tolerated in immunodeficiencies and immune thrombocytopenia. 144
Primary antibody deficiencies represent an underestimated comorbidity in asthma patients: efficacy of immunoglobulin replacement therapy in asthma control 142
Low-dose mepolizumab effectiveness in patients suffering from eosinophilic granulomatosis with polyangiitis 142
The anti-IgE monoclonal antibody omalizumab as adjuvant treatment in desensitization to carboplatin in patients with ovarian cancer 140
Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 in a Preliminary Study 140
"Sarcoidosis-like" granulomatous disease in patients with common variable hypogammaglobulinemia 139
A modified adenine chemically coupled to the allergen molecule of Dermatophagoides pteronyssinus redirects allergen-specific Th2 cells 139
EGPA Phenotyping: Not Only ANCA, but Also Eosinophils 138
Apten-specific proliferation as diagnostic tool in drug hypersensitivity. 137
Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunity 136
A modified adenine chemically coupled to allergen molecole redirects allergen-specific Th2 cells 135
COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey 134
Correlations Among Subcutaneous Immunoglobulin Dosage, Immunoglobulin G Serum Pre-infusional Levels and Body Mass Index in Primary Antibody Deficiency Patients: A Pooled Analysis from the SHIFT/IBIS Studies 133
Association between "sarcoidosis-like" disease and common variable immunodeficiency (CVI): a new CVI variant showing an activation of the immune system. 132
A modified adenine chemically coupled to allergen molecule(s) induce Interferon-gamma production and down regulate IL-4 and IL-5 in Th2 specific T cells 132
Modified adenine (9-benzyl-2-butoxy-8-hydroxyadenine) redirects Th2-mediated murine lung inflammation by triggering TLR7. 132
Safety and tolerability of infliximab therapy: suggestions and criticisms based on wide clinical experience. 131
Long-term effectiveness of benralizumab in severe eosinophilic asthma patients treated for 96-weeks: data from the ANANKE study 130
Total serum IgE levels influence the in vitro detection of ss-lactams-specific IgE antibodies 129
T cells specific for Candida albicans antigens and producing type 2 cytokines in lesional mucosa of untreated HIV-infected patients with pseudomembranous oropharyngeal candidiasis 127
Drug-specific Treg cells are induced during desensitization procedure for rituximab and tocilizumab in patients with anaphylaxis 126
A novel antigen-conjugated TLR7 ligand regulates the lung inflammation and Th2-mediated response in a murine model of asthma 125
A modified adenines chemically coupled to allergenic molecule(s) as inducerof allergen-specific Th2 cells redirection 125
Effectiveness of low-dose intravenous immunoglobulin therapy in minor primary antibody deficiencies: a two-year real-life experience 125
Modified adenine (9-benzyl-2-butoxy-8-hydroxyadenine) redirects Th2-mediated murine lung inflammation by triggering TLR7. 124
Long-term retention rate of mepolizumab treatment in severe asthma: a 36-months real-life experience 123
Coronary vasospasm during an acute allergic reaction 122
Effectiveness of tocilizumab in hospitalized moderate-to-severe COVID-19 patients: a real-life study 120
Persistence of both reversible airway obstruction and higher blood eosinophils may predict lung function decline in severe asthma 120
Allergological in vitro and in vivo evaluation of patients with hypersensitivity reactions to infliximab. 118
Baseline Eosinophil Count as a Potential Clinical Biomarker for Clinical Complexity in EGPA: A Real-Life Experience 115
Hydroxy-adenines as in vivo and in vitro immunomodulators of allergic responses 115
Alert Card for Patients on Biologicals and Immunosuppressives: An EAACI Position Paper 112
Modified adenines chemically coupled to allergen molecule induce interferon-gamma production and down-regulate IL-4 and IL-5 in Th2-specific T cells 112
Circulating T cells to infliximab are detectable mainly in treated patients developing anti-drug antibodies and hypersensitivity reactions 112
Anti-RuvBL1/2 Autoantibodies Detection in a Patient with Overlap Systemic Sclerosis and Polymyositis 112
Lack of efficacy of Cyclosporine A in a patient with episodic angioedema and eosinophilia (Gleich's syndrome) 109
Managing Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC) 108
Poly(I:C) promotes the production of IL-17A by murine CD1d-driven invariant NKT cells in airway inflammation. 108
Type 1 T helper cells specific for Candida albicans antigens in peripheral blood and vaginal mucosa of women with recurrent vaginal candidiasis. 108
The Kinetics of Antidrug Antibodies, Drug Levels, and Clinical Outcomes in Infliximab-Exposed Patients with Immune-Mediated Disorders 108
Multiorgan Infiltration by CD8+ T Cells and 1p;16p Translocation in a Patient with Hypogammaglobulinemia and a Reduced Number of B Cells. 107
Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent 107
Short and long-term effect of a novel nDer p2-conjugated TLR7 ligand in the prevention of allergic lung inflammation 106
Case Report: A child with NFKB1 haploinsufficiency explaining the linkage between immunodeficiency and short stature 105
Adalimumab and anti-adalimumab antibodies a novel method of detection and quantification in human sera based on surface plasmon resonance technique 102
Asthma:developments in targeted therapy. 102
Immediate adverse reactions to biologicals:from pathogenic mechanisms to prophylactic management 102
Highly active antiretroviral therapy including inhibitory proteases in HIV-infected patients induces a restored T cell-mediated immune response to C. albicans antigens and Th1 profile [abstract]. 101
T-cell responses during allergen-specific immunotherapy. 101
Influence of total serum IgE levels on the in vitro detection of beta-lactams-specific IgE antibodies. 100
Regulation of fetal allograft survival by hormone-controlled T cell cytokines 100
Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent 100
Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life 99
Immunogenicity of Biological Agents: Basic Knowledge and Clinical Implications 97
Benralizumab in Patients With Severe Eosinophilic Asthma With and Without Chronic Rhinosinusitis With Nasal Polyps: An ANANKE Study post-hoc Analysis 93
Totale 15.053
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.793
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.793
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021489 0 0 0 0 0 0 39 67 105 142 71 65
2021/2022657 20 60 45 19 23 36 33 59 25 32 134 171
2022/20231.843 150 367 92 148 133 313 231 98 218 14 45 34
2023/2024873 36 71 106 60 80 110 59 166 17 54 71 43
2024/20255.295 187 546 310 856 1.390 557 102 357 266 144 257 323
2025/20264.517 874 968 689 641 856 274 215 0 0 0 0 0
Totale 16.962